M. Tarallo

发表

Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis.

C. Blanchette, F. Ernst, C. Roberts, 2010, Clinical therapeutics.

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes

J. Baddley, J. Stephens, H. Schlamm, 2013, BMC Infectious Diseases.

US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host

J. Stephens, Xin Gao, M. Tarallo, 2011, Journal of medical economics.

Costs associated with non-medical switching from originator to biosimilar etanercept in patients with rheumatoid arthritis in the UK

M. Tarallo, S. Alexopoulos, K. Onishchenko, 2019, Journal of medical economics.

Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant

H. Schlamm, D. Marks, M. Tarallo, 2013, Journal of medical economics.

Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.

B. Kirkham, H. Nab, K. de Vlam, 2015, Clinical and experimental rheumatology.

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe

J. Cappelleri, M. Dibonaventura, A. Armuzzi, 2020, PloS one.

THU0363 A Structured Literature Review of the Burden of Illness and Unmet Needs in Patients with Rheumatoid Arthritis: A Current Perspective

M. Tarallo, P. Taylor, A. Moore, 2015 .

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

J. Piercy, P. Taylor, R. Caporali, 2018, RMD Open.

A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective

P. Taylor, J. Alvir, M. Tarallo, 2016, Rheumatology International.

The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe

J. Cappelleri, A. Armuzzi, M. Tarallo, 2020, BMC gastroenterology.

Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs.

R. Moots, J. Stephens, M. Tarallo, 2015, Clinical and experimental rheumatology.

Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study

M. Dougados, D. M. van der Heijde, W. Tsai, 2020, Health and Quality of Life Outcomes.

A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization

P. Emery, J. Cappelleri, I. Majer, 2015, Rheumatology International.

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

J. Piercy, P. Taylor, R. Caporali, 2018, Patient preference and adherence.

Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States

R. Chambers, M. Tarallo, A. Scott, 2022, Journal of medical economics.

PCN351 REAL WORLD EVIDENCE ON PATIENT CHARACTERISTICS AND FRONTLINE TREATMENT PATTERNS IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK FROM EUROPE AND US

J. Cappelleri, M. Tarallo, V. Pawar, 2020 .

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis

A. Reboli, D. Kett, C. Rotstein, 2011, PharmacoEconomics.

Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis.

C. Blanchette, F. Ernst, C. Roberts, 2010, Clinical therapeutics.